0001193125-18-304881.txt : 20181127 0001193125-18-304881.hdr.sgml : 20181127 20181023101458 ACCESSION NUMBER: 0001193125-18-304881 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20181023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 CORRESP 1 filename1.htm CORRESP

LOGO

4550 Towne Centre Court | San Diego, California | 92121

October 23, 2018

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. Street, N.E.

Washington, D.C. 20549

Attention: C. Westbrook

 

  Re:

La Jolla Pharmaceutical Company (the “Company”)

    

Registration Statement on Form S-3

    

File No. 333-227818

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 PM (Eastern Time) on October 25, 2018, or as soon thereafter as is practicable.

 

Very truly yours,

 

La Jolla Pharmaceutical Company

By:   /s/ Dennis M. Mulroy
Name:   Dennis M. Mulroy
Title:   Chief Financial Officer
GRAPHIC 2 g642424g1023132100567.jpg GRAPHIC begin 644 g642424g1023132100567.jpg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end